Overexpression of CSF-1 and/or FMS has been implicated in a number of disease states such as in the growth and metastasis of certain types of cancer, in the promotion of osteoclast proliferation in bone osteolysis, and in many inflammatory disorders [37–39]. This evidence concerns the gene CSF1R and cancer.